SEATTLE--(BUSINESS WIRE)--Frazier Healthcare Partners, a leading healthcare investment firm, today announced the promotion of Shyamal Swami to Principal on the Growth Buyout team.
Mr. Swami joined Frazier in 2016 and helped lead the investments in several of Frazier’s portfolio companies, including CSafe, CPS Solutions, and United Derm Partners. In addition, he played an instrumental role in several of Frazier’s exited portfolio companies, including United Digestive, Parata Systems, and The CORE Institute. Prior to joining Frazier, Mr. Swami was an Analyst in the healthcare investment banking group at Harris Williams & Co. in San Francisco, where he worked with middle-market companies on a variety of corporate finance and merger & acquisition engagements.
“We are pleased to congratulate Shyamal on his well-deserved promotion to Principal. His ability to integrate and partner with CEOs and management teams has led to several successful outcomes, including the recent exits of United Digestive and Parata,” said Ben Magnano, Managing Partner. “We have great confidence in his talents and dedication as a senior member of our team and are pleased to have him as our newest Principal.”
About Frazier Healthcare Partners:
Founded in 1991, Frazier Healthcare Partners is a leading private equity firm focused exclusively on the healthcare industry. Since its inception, Frazier has raised over $8 billion of capital for private funds and co-investment opportunities and has invested in more than 200 companies over 32 years. Frazier has a philosophy of partnering with strong management teams while leveraging its internal operating resources and network to build exceptional companies. Frazier is headquartered in Seattle, WA, and invests broadly across the U.S., Canada, and Europe.
For more information about Frazier, visit www.frazierhealthcare.com/growth-buyout .
